Canaccord Genuity Reiterates Hold On USANA Health Sciences, $78 PT
In a research report issued today, Canaccord Genuity analyst Scott Van Winkle reiterated a Hold rating on USANA Health Sciences (NYSE:USNA) with a price target of $78.00.
Winkle noted, “Growth challenges in the US keep our forecasts cautious, while the transition to China from Hong Kong has generally progressed better than we had anticipated. We maintain our HOLD rating. Investment highlights We expect a return to YOY revenue and earnings growth in Q3, but anticipate little changes to the overall trends. USNA anniversaried several changes made during Q3/13 to its compensation plan and pricing. As such, the results should better illustrate true growth in volume on a YOY basis. Strong distributor metrics in China entering Q3 are the positive for the revenue outlook, particularly against a very easy YOY comparison. The greatest source of upside could be an aggressive share repurchase.”
According to TipRanks.com, which measures analysts’ and bloggers’ success rate based on how their calls perform, analyst Scott Van Winkle has a total average return of 10.9% and a 58.6% success rate. Van Winkle has a average return when recommending USNA, and is ranked #162 out of 3336 analysts.